Enanta Pharmaceuticals
ENTA
#8060
Rank
ยฃ0.28 B
Marketcap
ยฃ9.94
Share price
4.27%
Change (1 day)
11.90%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -ยฃ37.62 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.25 Million. In 2025 the company made an earning of -ยฃ48.22 Million, an increase over its 2024 earnings that were of -ยฃ73.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ37.62 Million-21.98%
2025 -ยฃ48.22 Million-34.07%
2024 -ยฃ73.14 Million-23.87%
2023 -ยฃ96.07 Million4.39%
2022 -ยฃ92.03 Million-4.4%
2021 -ยฃ96.27 Million91.12%
2020 -ยฃ50.37 Million-407.13%
2019 ยฃ16.4 M-78.63%
2018 ยฃ76.75 M117.97%
2017 ยฃ35.21 M-574.65%
2016 -ยฃ7.42 Million-110.83%
2015 ยฃ68.52 M-4.5%
2014 ยฃ71.74 M-638.53%
2013 -ยฃ13.33 Million-137.98%
2012 ยฃ35.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.75 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.70 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ6.55 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.80 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.79 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.97 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA